Spots Global Cancer Trial Database for lung cancer, nonsmall cell

Every month we try and update this database with for lung cancer, nonsmall cell cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients	NCT04678440	Lung Cancer, No...	[18F]F-AraG Ima...	18 Years -	University of California, Davis
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)	NCT06231680	Lung Cancer, No... Esophageal Carc...	Camrelizumab Thalidomide 50m... Thalidomide 100... Thalidomide 200... Chemotherapy	18 Years -	Henan Cancer Hospital
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy	NCT04691817	Lung Cancer, No...	Atezolizumab Tocilizumab	18 Years -	Abramson Cancer Center at Penn Medicine
Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients	NCT04222335	Lung Cancer, No...	Blood samples	18 Years -	University Hospital, Toulouse
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients	NCT04678440	Lung Cancer, No...	[18F]F-AraG Ima...	18 Years -	University of California, Davis
Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating	NCT03322072	Lung Cancer Sta... Lung Cancer Sta... Lung Cancer, No... Lung Cancer Rec... Lung Cancer Sta...	Real-Time Posit...	18 Years - 85 Years	CancerCare Manitoba
Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection	NCT03704870	Lung Cancer Lung Diseases Lung Cancer, No... Surgery Lung Adenocarci...	Chest Xray No daily chest ...	18 Years -	University Health Network, Toronto
Plasmodium Immunotherapy for Lung Cancer	NCT02786589	Lung Cancer, No...	Blood-stage inf...	18 Years - 70 Years	State Key Laboratory of Respiratory Disease
Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment	NCT04440800	Lung Cancer, Sm... Pancreatic Canc... Gastric Cancer Oesophageal Can... Lung Cancer, No... Lung Cancer Met...	Wearable activi...	18 Years -	Royal Marsden NHS Foundation Trust
ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC	NCT06426511	Lung Cancer, No...	Toripalimab+Che... Toripalimab+Che...	18 Years - 75 Years	Sun Yat-sen University
Palliative Thoracic ImmunoRT	NCT03705806	Lung Cancer, No... Lung Cancer	Radiation combi...	18 Years -	University Health Network, Toronto
Effect of Qigong on the Symptom Clusters of Dyspnea, Fatigue, and Anxiety.	NCT02977845	Lung Cancer, No... Lung Cancer Non... Lung Cancer, No... Lung Cancer Non... Lung Cancer, Li...	Qigong	18 Years -	Nam Dinh University of Nursing
High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases	NCT06319950	Lung Cancer, No...	Furmonertinib Osimertinib	18 Years - 80 Years	Taizhou Hospital
Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy	NCT05472350	Lung Cancer, No... Perioperative Cough Drug Effect Drug Toxicity	Breztri Aerosph... Placebo	18 Years - 75 Years	The First Affiliated Hospital of Guangzhou Medical University
Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC	NCT03008109	Advanced Cancer Lung Cancer, No...	EGFR-TK Inhibit...	18 Years -	Air Force General Hospital of the PLA
Move For Surgery - A Novel Preconditioning Program	NCT03689634	Lung Cancer, No...	Move For Surger...	18 Years -	St. Joseph's Healthcare Hamilton
Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan	NCT06293833	Lung Cancer, No... Lung Cancer Smoking Cessati... Lung Cancer, Sm...	Low-dose CT sca... Smoking Cessati...	55 Years - 74 Years	University Hospital, Antwerp
A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer	NCT06405815	Lung Cancer, No...	tumor and perit...	18 Years -	Jinling Hospital, China
Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA	NCT03499678	Lung Cancer Lung Cancer, No... Lung Cancer, Sm...		18 Years -	HKGepitherapeutics
Move for Surgery (MFS): Evaluating the Use of Wearable Technology for Preconditioning Before Thoracic Surgery	NCT03902834	Preconditioning Lung Cancer, No...	Fitbit	-	St. Joseph's Healthcare Hamilton
Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers	NCT05860296	Lung Cancer, No... Lung Cancer Sta... Lung Cancer Met...	SLC-391 pembrolizumab	18 Years -	SignalChem Lifesciences Corporation
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients	NCT05415358	Lung Cancer, No...	Blood and tissu...	18 Years -	Wake Forest University Health Sciences
Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection	NCT03704870	Lung Cancer Lung Diseases Lung Cancer, No... Surgery Lung Adenocarci...	Chest Xray No daily chest ...	18 Years -	University Health Network, Toronto
Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLC	NCT04028778	Lung Cancer, No...	Gefitinib Anlotinib Hydro... Placebo	18 Years - 75 Years	Sun Yat-sen University
Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC)	NCT02950038	Lung Cancer, No...	Ibrutinib Nivolumab	18 Years -	M.D. Anderson Cancer Center
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer	NCT02995889	Lung Cancer, No... Small Cell Lung...	FLT-PET	18 Years -	Rigshospitalet, Denmark
Palliative Thoracic ImmunoRT	NCT03705806	Lung Cancer, No... Lung Cancer	Radiation combi...	18 Years -	University Health Network, Toronto
Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating	NCT03322072	Lung Cancer Sta... Lung Cancer Sta... Lung Cancer, No... Lung Cancer Rec... Lung Cancer Sta...	Real-Time Posit...	18 Years - 85 Years	CancerCare Manitoba
Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer	NCT05863013	Lung Cancer, No... Quality of Life Physical Disabi... Surgery	ADL-Glittre Tes...	18 Years -	Centro Universitário Augusto Motta
Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)	NCT04611867	Pancreatic Canc... Lung Cancer, No...	Supportive appl...	18 Years -	Herlev Hospital
Breathe Easier II: A Dyad-based Multiple Behavior Intervention	NCT05956782	Lung Cancer, No... COPD Self-Management Physical Inacti... Stress Quality of Life	Breathe Easier	21 Years -	University of South Carolina
I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy	NCT05537922	Non Small Cell ... Lung Cancer Met... Lung Cancer, No... Lung Adenocarci...		18 Years -	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Multicenter Cancer Biospecimen Collection Study	NCT04510129	Cancer of Head ... Lung Cancer, No... Small-cell Lung... Urothelial Carc... Gastroesophagea... Cervical Cancer Esophageal Squa... Triple Negative... Hepatocellular ... Renal Cell Carc... Colorectal Canc...	OncoPrism™ assa...	18 Years -	Cofactor Genomics, Inc.
Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers	NCT05860296	Lung Cancer, No... Lung Cancer Sta... Lung Cancer Met...	SLC-391 pembrolizumab	18 Years -	SignalChem Lifesciences Corporation
Folate One-carbon Malnutrition as the Metabostemness Risk Factor of Malignancy Tumor Development of NSCLC Patients	NCT03504098	Lung Cancer, No...	nutrition consu...	20 Years - 90 Years	National Taiwan University Hospital
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients	NCT04678440	Lung Cancer, No...	[18F]F-AraG Ima...	18 Years -	University of California, Davis
Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer	NCT05384873	Lung Cancer, No...	Immunonutrition Control dietary...	18 Years -	IRCCS Policlinico S. Matteo
Effect of Exercise Training in Lung Cancer	NCT05158530	Lung Cancer, No...	Aerobic trainin... Pulmonary Exerc...	20 Years - 55 Years	Riphah International University
Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.	NCT03245736	Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer Esophagus Cance... Lung Cancer, No... Squamous Cell C...	Tisotumab Vedot...	18 Years -	Seagen Inc.
A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer	NCT06405815	Lung Cancer, No...	tumor and perit...	18 Years -	Jinling Hospital, China
Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan	NCT06293833	Lung Cancer, No... Lung Cancer Smoking Cessati... Lung Cancer, Sm...	Low-dose CT sca... Smoking Cessati...	55 Years - 74 Years	University Hospital, Antwerp
Folate One-carbon Malnutrition as the Metabostemness Risk Factor of Malignancy Tumor Development of NSCLC Patients	NCT03504098	Lung Cancer, No...	nutrition consu...	20 Years - 90 Years	National Taiwan University Hospital
Plasmodium Immunotherapy for Lung Cancer	NCT02786589	Lung Cancer, No...	Blood-stage inf...	18 Years - 70 Years	State Key Laboratory of Respiratory Disease
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients	NCT04237805	Advanced Cancer Advanced Solid ... Lung Cancer, No...	SAF-189s	18 Years -	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC)	NCT02950038	Lung Cancer, No...	Ibrutinib Nivolumab	18 Years -	M.D. Anderson Cancer Center
A Multicenter Cancer Biospecimen Collection Study	NCT04510129	Cancer of Head ... Lung Cancer, No... Small-cell Lung... Urothelial Carc... Gastroesophagea... Cervical Cancer Esophageal Squa... Triple Negative... Hepatocellular ... Renal Cell Carc... Colorectal Canc...	OncoPrism™ assa...	18 Years -	Cofactor Genomics, Inc.
Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer	NCT03088930	Lung Cancer, No...	Crizotinib	18 Years - 100 Years	University of Colorado, Denver
Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity	NCT04631731	Lung Cancer, No... Renal Cell Carc... Melanoma Gastric Cancer Hepatocellular ... Endometrial Can... Mesothelioma	Blood screening Tissue screenin...	-	Western Sydney Local Health District
Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer	NCT03377023	Non Small Cell ... Lung Cancer, No... Non Small Cell ...	Nivolumab Ipilimumab Nintedanib	18 Years -	H. Lee Moffitt Cancer Center and Research Institute
Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.	NCT03245736	Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer Esophagus Cance... Lung Cancer, No... Squamous Cell C...	Tisotumab Vedot...	18 Years -	Seagen Inc.
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer	NCT02995889	Lung Cancer, No... Small Cell Lung...	FLT-PET	18 Years -	Rigshospitalet, Denmark
Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy	NCT05472350	Lung Cancer, No... Perioperative Cough Drug Effect Drug Toxicity	Breztri Aerosph... Placebo	18 Years - 75 Years	The First Affiliated Hospital of Guangzhou Medical University
Cios Mobile 3D Spin for Robotic Bronchoscopy	NCT04740047	Pulmonary Nodul... Pulmonary Cance... Lung Cancer Lung Cancer, No... Lung Adenocarci...	Ion Endoluminal...	18 Years -	Mayo Clinic
Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC	NCT02991651	Lung Cancer, No...	IRX4204 erlotinib	18 Years -	Io Therapeutics
FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer	NCT02995889	Lung Cancer, No... Small Cell Lung...	FLT-PET	18 Years -	Rigshospitalet, Denmark
X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases	NCT04415320	Lung Cancer, No... Brain Metastase...	X-396(Ensartini...	18 Years -	Betta Pharmaceuticals Co., Ltd.
Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)	NCT04611867	Pancreatic Canc... Lung Cancer, No...	Supportive appl...	18 Years -	Herlev Hospital
Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer	NCT05863013	Lung Cancer, No... Quality of Life Physical Disabi... Surgery	ADL-Glittre Tes...	18 Years -	Centro Universitário Augusto Motta
Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)	NCT04638582	Lung Cancer, No...	Pembrolizumab Carboplatin Paclitaxel Pemetrexed	18 Years -	McGill University Health Centre/Research Institute of the McGill University Health Centre
Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients	NCT04222335	Lung Cancer, No...	Blood samples	18 Years -	University Hospital, Toulouse
Induction Chemo-Nivo in Unresectable Stage III NSCLC	NCT06003075	Lung Cancer, No... Lung Cancer Sta...	Nivolumab and C... Nivolumab Post Induction ... Post Induction ...	18 Years -	University of Kentucky
Prediction Model of ICIs Combined With Chemotherapy in Advanced NSCLC	NCT05725915	Lung Cancer, No...		18 Years -	Beijing Red Clove Public Welfare Development Center
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients	NCT04566432	Lung Neoplasms Lung Cancer, No... Adenocarcinoma ... Squamous Cell L...	Observation	18 Years -	Geneplus-Beijing Co. Ltd.
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy	NCT04691817	Lung Cancer, No...	Atezolizumab Tocilizumab	18 Years -	Abramson Cancer Center at Penn Medicine
High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases	NCT06319950	Lung Cancer, No...	Furmonertinib Osimertinib	18 Years - 80 Years	Taizhou Hospital

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: